51，Gavg R,Yusuf S.Overview of randomized trial of angiotensin -converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE inhibitors.JAMA,1995;273(18):1450 被引量：1
62，CIBIS-Ⅱ Investigators and Committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ)a randomised trial.Lancet,1999;353(9146):9 被引量：1
73，MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure(MERIT-HF).Lancet,1999;353(9169):2001 被引量：1
8Leonetti G and Cuspidi C. Choosing the right ACE inhibitor:A guid to selection. Drugs, 1995;49(4):516. 被引量：1
9Maschio G, Alberti D, Janin G, et al. Effect of angiotensin-convertion-enzyme inhibition benazepril on progression on the progression of chronic renal insufficiency. N Engl J Med,1996;334:939. 被引量：1
10Yokoyama Htomonaga O,Hirayama M, et al. Predictors of progression of diabetic nephropathy and the beneficial, effect of angiotensin-converting enzyme inhibitiors in NIDDM patients. Diabetologia, 1997;40:405. 被引量：1
4[1]Ondetti M A,Rubin B,Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents[J]. Science, 1977,196: 441-444. 被引量：1
5[2]Ondetti M A,Cushman DW. Enzymes of the renin angiotensin system and their inhibitors[J].Annu Rev Biochem, 1982,51:283-308. 被引量：1
6[3]Cohen M L. Synthetic and fermentation-derived angiotensinconverting enzyme inhibitors[J].Annu Rev Pharmacol Toxicol,1985, 25: 307-323. 被引量：1
7[4]Leonetti G,Cuspidi C. Choosing the right ACE inhibitor-A guide to selection[J]. Drugs, 1995, 49(4): 516. 被引量：1
9[7]Unger T, Ganten D, Long RE. Converting enzyme inhibitors:antihypertensive drugs with unexpected mechanisms[J]. Trends in Pharmacol Sci, 1983, 4: 514-519. 被引量：1
10[8]Antonaccio MJ, Kerwin L. Pre-and post junctional inhibition of vascular sympathetic function by captopril in SHR, implication and antihypertensive actions of captopril[J]. Hypertension, 1981,3(3ptz): 154-162. 被引量：1
